Pallet, Nicolas
Hamdane, Salma
Garinet, Simon
Blons, Hélène
Zaanan, Aziz
Paillaud, Elena
Taieb, Julien
Laprevote, Olivier
Loriot, Marie-Anne
Narjoz, Céline
Funding for this research was provided by:
Institut National Du Cancer
Article History
Received: 17 February 2020
Revised: 2 June 2020
Accepted: 11 June 2020
First Online: 29 June 2020
Ethics approval and consent to participate
: This study received approval (N° 00011928) from the hospital institutional review board (CERAPHP.5). All patients provided written informed consent for study participation and for genetic analyses prior to inclusion. The study has been performed in accordance with the Declaration of Helsinki.
: Data supporting the results reported in the article can be obtained upon request to the corresponding author.
: The authors declare no competing interests.
: French National Cancer Institute (Institut National du Cancer, INCa) and Canceropôle Ile de France have provided financial support for this work, none of which has any role in the design and conduct of the study, the collection, management, analysis, and interpretation of data, the preparation, review and approval of the paper or the decision to submit the paper for publication.